VITAMIN-E AS AN ADJUVANT IN AN ESCHERICHIA-COLI J5 VACCINE

被引:14
|
作者
HOGAN, JS [1 ]
WEISS, WP [1 ]
SMITH, KL [1 ]
TODHUNTER, DA [1 ]
SCHOENBERGER, PS [1 ]
WILLIAMS, SN [1 ]
机构
[1] HOFFMANN LA ROCHE INC, NUTLEY, NJ 07110 USA
关键词
VITAMIN-E; ADJUVANT; VACCINE;
D O I
10.3168/jds.S0022-0302(93)77359-2
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Vitamin E was tested as an adjuvant in an Escherichia coli (O111:B4) J5 vaccine. Twenty cows were assigned to five groups of 4 cows. Cows in four groups were vaccinated with an E. coli J5 bacterin containing 5 ml of 10(9) boiled cells/ml. Vaccinations were at drying off, 30 d after drying off, and within 48 h after calving. Vaccine adjuvants differed among groups. The four treatment adjuvants were 5 ml of Freund's incomplete adjuvant, 5 ml of vitamin E, 2.5 ml of Freund's plus 2.5 ml of vitamin E, and 5 ml of PBS. Cows in the fifth group were unimmunized controls. A front mammary quarter of each cow was challenged by infusion of 10 mug of E. coli J5 lipopolysaccharide approximately 4 wk into lactation. Vitamin E alone enhanced serum IgM titers but had no effect on milk IgM or serum and milk IgG titers. The mixture of Freund's plus vitamin E resulted in peak IgG titers in serum and milk comparable with that of Freund's alone. Persistency of IgG titers in cows immunized with the Freund's plus vitamin E mixture was greater than the persistency of titers for cows immunized with the vaccine containing Freund's alone as the adjuvant. The mixture of Freund's plus vitamin E had a synergistic effect in reducing severity of systemic clinical signs.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 50 条
  • [1] HETEROGENEITY OF ESCHERICHIA-COLI J5 VACCINES
    APPELMELK, BJ
    RAPSON, NT
    VERWEIJVANVUGHT, AMJJ
    MAASKANT, JJ
    HEKKER, TAM
    PEERBOOMS, PGH
    MACLAREN, DM
    THIJS, LG
    [J]. LANCET, 1986, 2 (8518): : 1273 - 1274
  • [2] HETEROGENEITY OF ESCHERICHIA-COLI J5 STRAINS
    EVANS, ME
    POLLACK, M
    KOLES, N
    APPELMELK, BJ
    [J]. CLINICAL RESEARCH, 1990, 38 (02): : A393 - A393
  • [3] EFFECT OF ESCHERICHIA-COLI J5 VACCINE AND INTRAMAMMARY CHALLENGE WITH LIVE ESCHERICHIA-COLI IN LACTATING DAIRY GOATS
    ASLAM, M
    WHITEMORE, HL
    KAKOMA, I
    [J]. SMALL RUMINANT RESEARCH, 1995, 17 (03) : 275 - 281
  • [4] FIELD TRIAL TO DETERMINE EFFICACY OF AN ESCHERICHIA-COLI J5 MASTITIS VACCINE
    HOGAN, JS
    SMITH, KL
    TODHUNTER, DA
    SCHOENBERGER, PS
    [J]. JOURNAL OF DAIRY SCIENCE, 1992, 75 (01) : 78 - 84
  • [5] EFFICACY OF AN ESCHERICHIA-COLI J5 MASTITIS VACCINE IN AN EXPERIMENTAL CHALLENGE TRIAL
    HOGAN, JS
    WEISS, WP
    TODHUNTER, DA
    SMITH, KL
    SCHOENBERGER, PS
    [J]. JOURNAL OF DAIRY SCIENCE, 1992, 75 (02) : 415 - 422
  • [6] IMMUNIZATION OF DAIRY-COWS WITH AN ESCHERICHIA-COLI J5 LIPOPOLYSACCHARIDE VACCINE
    TOMITA, GM
    TODHUNTER, DA
    HOGAN, JS
    SMITH, KL
    [J]. JOURNAL OF DAIRY SCIENCE, 1995, 78 (10) : 2178 - 2185
  • [7] PROPHYLACTIC ROLE FOR ANTIBODIES TO ESCHERICHIA-COLI J5
    GOULD, FK
    FREEMAN, R
    [J]. LANCET, 1987, 1 (8526): : 215 - 215
  • [8] FATE OF THE LIPID-A AND POLYSACCHARIDE COMPONENTS OF ESCHERICHIA-COLI J5 LIPOPOLYSACCHARIDE FOLLOWING THE INGESTION OF ESCHERICHIA-COLI J5 BY MURINE MACROPHAGES INVITRO
    DUNCAN, RL
    ZIEGLER, HK
    MORRISON, DC
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1984, 6 (04): : 573 - 574
  • [9] ANTIGENIC AND IMMUNOGENIC DIFFERENCES IN LIPOPOLYSACCHARIDES OF ESCHERICHIA-COLI J5 VACCINE STRAINS OF DIFFERENT ORIGINS
    APPELMELK, BJ
    MAASKANT, JJ
    VERWEIJVANVUGHT, AMJJ
    VANDERMEER, NM
    THIJS, BG
    MACLAREN, DM
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 : 2641 - 2647
  • [10] CHARACTERIZATION OF MURINE MONOCLONAL-ANTIBODIES TO ESCHERICHIA-COLI J5
    MINER, KM
    MANYAK, CL
    WILLIAMS, E
    JACKSON, J
    JEWELL, M
    GAMMON, MT
    EHRENFREUND, C
    HAYES, E
    CALLAHAN, LT
    ZWEERINK, H
    SIGAL, NH
    [J]. INFECTION AND IMMUNITY, 1986, 52 (01) : 56 - 62